TB-500 vs Tesamorelin
A comprehensive, data-driven comparison of TB-500 (Thymosin Beta-4) and Tesamorelin (Egrifta). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | TB-500 Thymosin Beta-4, Tβ4 | Tesamorelin Egrifta, TH9507 |
|---|---|---|
| FDA Status | Category 2 (pending reclassification) | FDA Approved |
| Category | Recovery & Healing | Growth Hormone |
| Primary Use | Tissue repair and injury recovery | HIV-associated lipodystrophy |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $40 - $80/mo | $200 - $1,500/mo |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Typical Dose | 2-5mg twice weekly | 2mg daily |
| Frequency | Twice weekly | Daily |
| Mechanism | Synthetic version of thymosin beta-4 that promotes cell migration, reduces inflammation, and accelerates wound healing | Synthetic GHRH analog that reduces visceral adipose tissue by stimulating growth hormone production |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Low | High |
| Clinical Trial Phase | N/A | Approved |
Key Differences
- 1Tesamorelin is FDA-approved, while TB-500 is currently category 2 (pending reclassification).
- 2TB-500 is generally more affordable ($40 - $80/mo) compared to Tesamorelin ($200 - $1,500/mo).
- 3TB-500 is dosed twice weekly, while Tesamorelin is daily.
- 4Tesamorelin has high-quality evidence, while TB-500 has low-quality evidence.
- 5They belong to different categories: TB-500 (Recovery & Healing) vs Tesamorelin (Growth Hormone).
Which Is Better For...
Tesamorelin
Those seeking an FDA-approved treatment with established safety data
TB-500
More budget-friendly option with lower monthly costs
TB-500
More convenient dosing schedule (twice weekly)
TB-500
Fewer commonly reported side effects
Tesamorelin
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| TB-500 | $40 - $80/mo | Category 2 (pending reclassification) | Various research labs |
| Tesamorelin | $200 - $1,500/mo | FDA Approved | Theratechnologies |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
TB-500 works via Synthetic version of thymosin beta-4 that promotes cell migration, reduces inflammation, and. Tesamorelin works via Synthetic GHRH analog that reduces visceral adipose tissue by stimulating growth hormone. They differ in FDA approval status, efficacy data, and cost.
TB-500 typically costs $40 - $80/mo, while Tesamorelin costs $200 - $1,500/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
TB-500 is not FDA-approved (Category 2 (pending reclassification)). Tesamorelin is FDA-approved. FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of TB-500 include Injection site reactions, Mild fatigue, Headache. Common side effects of Tesamorelin include Injection site reactions, Arthralgia, Peripheral edema. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
TB-500 is a synthetic version of the naturally occurring peptide Thymosin Beta-4, which plays a crucial role in tissue repair and regeneration. It promotes the migration of endothelial and keratinocyt...
View Full TB-500 GuideTesamorelin is an FDA-approved synthetic growth hormone releasing hormone analog specifically indicated for reducing excess abdominal fat in HIV-infected patients with lipodystrophy. A new weekly reco...
View Full Tesamorelin GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between TB-500 and Tesamorelin should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.